KBI Biopharma is headed to Japan for the Antibody Society of Japan Annual Meeting this December!
Schedule a meeting >>
Meet with the KBI Biopharma Team:
KBI Biopharma is a leading global contract development and manufacturing organization (CDMO) providing fully integrated, accelerated drug development and biologics manufacturing services and expertise to life science companies. With each of our 1400+ client partners, we work closely to personalize and accelerate drug development programs. Built upon a foundation of world-class analytics capabilities and extensive scientific and technical expertise, we deliver robust process development and clinical and commercial cGMP manufacturing services for mammalian and microbial programs. Recognized for quality manufacturing, we help clients advance drug candidates into the clinic and beyond.
Learn more about KBI Biopharma >>
The Antibody Society of Japan's annual meeting brings together academic and industry experts to share the latest advances in antibody engineering, drug discovery, and bioanalysis through presentations, networking, and collaboration opportunities.